Pioneers of the world’s first TCR therapy
We are a commercial-stage T cell receptor (TCR) biotechnology company that is pioneering and delivering transformative immunomodulating medicines to radically improve outcomes for patients living with cancer, infectious diseases, and autoimmune diseases.